The global home infusion therapy market size was valued at USD 41.65 billion in 2025 and is projected to grow from USD 44.99 billion in 2026 to USD 83.47 billion by 2034, registering a CAGR of 8.03% during the forecast period from 2026 to 2034. North America dominated the home infusion therapy market with a market share of 42.6% in 2025.
Advances in home infusion therapy are transforming care delivery from hospital-centric treatment to patient-managed, decentralized models, improving outcomes and reducing healthcare costs. The rising prevalence of chronic diseases, including diabetes, cancer, and immune disorders, is driving demand for long-term intravenous therapies administered at home. The International Diabetes Federation 2025 stated that approximately 589 million adults aged 20-79 are living with diabetes.
Clinical studies indicate that home infusion can lower hospitalization rates by over 20% while enhancing patient satisfaction and adherence. Technological innovations such as portable infusion pumps, elastomeric devices, and smart monitoring systems improve safety, dosing accuracy, and mobility. Expanding aging populations and increased preference for cost-effective care settings further accelerate market growth. Opportunities are emerging through partnerships with home healthcare providers, specialty pharmacies, and digital health platforms.
Download a Free Sample To learn more about this report,
Increasing Shift Toward Home-Based and Patient-Centered Infusion Care
Home infusion therapy is increasingly being adopted as an alternative to prolonged hospital-based treatment for patients requiring intravenous or subcutaneous therapies. The shift toward home care can reduce facility visits, improve patient mobility, and support treatment continuity while helping healthcare systems manage costs and capacity more efficiently.
Growing Integration of Smart Infusion Devices and Remote Monitoring Technologies
Home infusion services are increasingly incorporating portable smart infusion pumps, wireless connectivity, telehealth platforms, and remote monitoring capabilities. These technologies enable healthcare professionals to track therapy remotely, identify potential complications, support adherence, and adjust treatment plans while reducing the need for frequent in-person visits.
Rising Prevalence of Chronic Diseases and Increasing Need for Prolonged Infusion Therapies Support Home Infusion Therapy Market Growth
The increasing prevalence of cancer, diabetes, immune deficiencies, chronic infections, and other conditions requiring prolonged medication administration is expanding the overall need for infusion therapies. The growing use of intravenous antibiotics, immunoglobulins, specialty pharmaceuticals, nutrition therapies, and other infused treatments is increasing demand for reliable infusion services across healthcare settings and supporting continued market growth.
High Costs and Complex Care Coordination Requirements Can Limit Home Infusion Therapy Adoption
Home infusion therapy requires infusion equipment, medications, nursing support, patient training, vascular access management, monitoring, and coordination among healthcare providers and pharmacies. These requirements can increase service costs and operational complexity, particularly for patients with limited caregiver support or healthcare systems with restricted reimbursement coverage.
Expansion of Specialty Pharmaceuticals and Complex Therapies in Home Settings Creates New Growth Opportunities
The growing availability of biologics, immunoglobulin therapies, specialty pharmaceuticals, anti-infectives, and other complex treatments is expanding the range of therapies that can potentially be delivered at home. Improvements in patient selection, clinical support, portable infusion technologies, and remote monitoring can enable more high-value therapies to transition from institutional settings to coordinated home-care programs.
Maintaining Infection Control, Patient Safety, and Reliable Clinical Monitoring Creates Challenges
Home infusion therapy requires strict medication handling, vascular access care, infection-control procedures, accurate device operation, and timely clinical intervention when complications occur. Delivering these requirements outside controlled healthcare facilities can create challenges related to patient training, caregiver capability, monitoring consistency, emergency response, and maintaining high standards of clinical quality.
Services Segment is Projected to Register the Fastest Growth at a CAGR of 8.9%
The services segment is projected to register the fastest growth at a CAGR of 8.9% during 2026–2034. In 2025, the segment accounted for 38.5% of the global home infusion therapy market, with a value of USD 16.04 billion. Growth is driven by increasing preference for home-based healthcare, rising demand for specialized infusion services, and the growing need for convenient treatment outside traditional healthcare facilities. Expanding home healthcare infrastructure and increasing adoption of patient-centered care continue to support the segment's growth.
The products segment dominated the market with a 61.5% share and a value of USD 25.61 billion. Its leading position is supported by the widespread use of infusion pumps, intravenous sets, IV cannulas, and needleless connectors in home-based infusion therapy. Increasing demand for reliable infusion equipment and advances in portable medical devices continue to reinforce the segment's market position.
Request Customizationto receive a tailored report.
Infusion Pumps Segment is Projected to Register the Fastest Growth at a CAGR of 8.7%
The infusion pumps segment is projected to register the fastest growth at a CAGR of 8.7% during 2026–2034. In 2025, the segment accounted for 43.2% of the global home infusion therapy market, with a value of USD 17.99 billion. Growth is driven by increasing demand for controlled and accurate medication delivery, rising adoption of portable infusion technologies, and growing preference for home-based treatment. Technological advancements in pump design and improved patient safety features continue to support the segment's growth.
The intravenous sets segment accounted for 27.4% of the market, with a value of USD 11.41 billion and a CAGR of 8.2%. IV cannulas represented 18.6% of the market, while needleless connectors accounted for 10.8%. These products continue to support home infusion therapy by enabling safe, efficient, and reliable administration of intravenous treatments.
Specialty Pharmaceuticals Segment is Projected to Register the Fastest Growth at a CAGR of 9.4%
The specialty pharmaceuticals segment is projected to register the fastest growth at a CAGR of 9.4% during 2026–2034. In 2025, the segment accounted for 12.1% of the global home infusion therapy market, with a value of USD 5.04 billion. Growth is driven by increasing availability of complex specialty medicines, rising demand for personalized treatment, and growing adoption of home-based administration for therapies that previously required healthcare facility visits. Expanding access to specialty pharmaceutical treatments continues to support the segment's growth.
The anti-infective segment dominated the market with a 24.7% share and a value of USD 10.29 billion, owing to the widespread use of home infusion therapy for prolonged antimicrobial treatment. Chemotherapy accounted for 14.8%, followed by endocrinology at 13.6% and enteral nutrition at 12.4%. Hydration therapy and parenteral nutrition continue to contribute to market growth through increasing demand for supportive and long-term home-based therapies.
Speak to an Analystto discuss market opportunities.
North America home infusion therapy market accounted for 42.6% of the global market, reaching USD 17.74 billion in 2025, and is projected to grow at a CAGR of 7.9% during the forecast period. The market is driven by increasing prevalence of chronic diseases, growing demand for home-based healthcare, rising healthcare costs, and increasing preference for convenient and personalized treatment options. Expanding home healthcare infrastructure and advancements in infusion technologies continue to support regional market growth.
The US market was valued at USD 15.08 billion in 2025, making it the largest contributor in North America. Increasing demand for home-based treatment, growing prevalence of chronic conditions, rising healthcare expenditure, and expanding adoption of portable infusion devices continue to drive market growth.
Canada's market reached USD 2.66 billion in 2025. Growing demand for home healthcare services, increasing aging population, expanding access to infusion therapy, and rising adoption of advanced home infusion technologies continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe home infusion therapy market accounted for 27.8% of the global market, reaching USD 11.58 billion in 2025, and is projected to grow at a CAGR of 7.6% during the forecast period. Increasing prevalence of chronic diseases, growing adoption of home healthcare services, rising healthcare expenditure, and increasing demand for cost-effective treatment alternatives continue to strengthen regional market growth. Expanding healthcare infrastructure and greater patient preference for home-based care further support market expansion.
The UK market was valued at USD 2.32 billion in 2025. Increasing demand for community-based healthcare, growing prevalence of chronic diseases, expanding home treatment programs, and rising adoption of advanced infusion technologies continue to support market growth.
Germany market accounted for USD 3.24 billion in 2025. Strong healthcare infrastructure, increasing demand for home-based medical care, growing elderly population, and rising investments in advanced infusion systems continue to drive market expansion.
Asia Pacific home infusion therapy market accounted for 19.7% of the global market, reaching USD 8.21 billion in 2025, and is projected to grow at a CAGR of 10.3% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of chronic diseases, growing healthcare expenditure, and rising demand for home-based treatment continue to accelerate regional market growth. Increasing awareness of home healthcare and expanding access to advanced infusion technologies further strengthen market expansion.
China's market accounted for USD 3.45 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing demand for home-based care, growing chronic disease burden, and rising investments in healthcare technologies continue to drive market expansion.
Japan's market generated USD 1.48 billion in 2025. Increasing elderly population, growing demand for home healthcare, expanding adoption of portable infusion devices, and rising healthcare modernization continue to support market growth.
Middle East and Africa home infusion therapy market accounted for 4.1% of the global market, totaling USD 1.71 billion in 2025, and is projected to grow at a CAGR of 7.4% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of chronic diseases, expanding home healthcare services, and rising awareness of home-based treatment options continue to support regional market growth.
The UAE market was valued at USD 0.43 billion in 2025. Increasing investments in advanced healthcare infrastructure, growing demand for home-based medical services, expanding private healthcare facilities, and rising adoption of innovative infusion technologies continue to drive market growth.
Africa's market reached USD 1.28 billion in 2025. Expanding healthcare access, increasing investments in healthcare infrastructure, growing demand for affordable home-based treatment, and rising awareness of infusion therapy continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Asia Pacific Electrocardiograph (ECG) Market Size, Share Trend Analysis by 2034
Middle East and Africa Dental Intraoral Scanners Market Size, 2034
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
We are featured on:
sales@straitsresearch.com